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Abstract
Multimorbidity is a growing issue and poses a major challenge to health care systems around the world. Multimorbidity
is related to ageing but many studies have now shown that it is also socially patterned, being more common
and occurring at an earlier age in areas of high socioeconomic deprivation. There is lack of research on patients with
multimorbidity, and thus guidelines are based on single-conditions. Polypharmacy is common in multimorbidity,
increasing drug-disease and drug-drug interactions. Multimorbid patients need holistic care, but secondary care
services are highly specialised and thus are often duplicative and fragmented and thus increase treatment burden in
multimorbid patients. The cost of care is high in multimorbidity, due to high rates of primary and secondary care
consultations and unplanned hospital admissions. The combination of mental and physical conditions increases
complexity of care, and costs. Mental-physical multimorbidity is especially common in deprived areas.
General practitioners and primary care teams have a key role in managing patients with multimorbidity, using a
patient-centred generalist approach. Consultation length and continuity of care may need to be substantially
enhanced in order to enable such patients. This will require a radical change in how health care systems are organised
and funded in order to effectively meet the challenges of multimorbidity.
Background
Multimorbidity, commonly defined as the co-existence
of two or more chronic conditions within an individual
[1], is now the norm in ageing populations around the
world [2]. Furthermore, it is socially patterned, occurring
more often and at an earlier age in patients of lower so-
cioeconomic status (SES) [2, 3]. Thus multimorbidity
should not be considered exclusively as an issue of older
age, and affects many people of working age [3, 4].
There are multiple challenges in managing patients with
multimorbidity, some of which are discussed below.
Evidence base and guidelines
Research and guidelines on the management of long
term conditions has routinely focused on single dis-
eases [2, 5]. Patients with multimorbidity are usually
excluded from randomised controlled trials [3, 6].
This has led to individual disease management rather
than a more holistic approach [5]. A recent system-
atic review of interventions for patients with
multimorbidity found only ten studies worldwide [7].
There was a particular dearth of studies in high
deprivation settings, or that focused on patients with
low SES [7].
There is a thus an urgent need for more interventions
to be tested in pragmatic trials in multimorbid popula-
tions, especially in relation to health inequalities, and for
these to inform future guidelines. A NICE guideline on
the clinical assessment and management of multimorbid-
ity is expected to be published next year [8]. Although this
will provide welcome guidance to this complex area of
practice, the advice is likely to be generic rather than
specific, given the paucity of research to date.
Polypharmacy
Drug therapy in multimorbidity is a common area of
difficulty for both patients and physicians [5, 9, 10].
Polypharmacy is common in multimorbidity because
guidelines are single-disease focused and advise when
to start new drugs but seldom when to stop them.
The more LTCs (long term conditions) a patient has
the more medications they are likely to be prescribed
[4, 11, 12]. Polypharmacy commonly leads to drug-
disease interaction and drug-drug interactions [10, 13].
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Specialism
Healthcare systems are largely based around a single-
disease paradigm and thus specialist care of the multi-
morbid patients is often fragmented and duplicative with
an increasing trend toward super-specialism [1, 3, 14].
This can create multiple problems and barriers to holis-
tic patient centred care. The pivotal role of generalism
in the management of patients with multimorbidity is
becoming increasingly evident. Although in some sys-
tems this function can be provided by a general phys-
ician or internist, in countries with a well-developed
primary care system, such as in the UK, much of this
role depends on general practitioners (GPs) [15]. Expert
generalist care is not just medical care for several condi-
tions, but crucially combines the biotechnical with the
biographical, in what has been termed interpretive medi-
cine [15] in which a patient-centred approach is tailored
to each patients circumstances and choices.
Treatment burden
Treatment burden describes the demand which patients
and their caregivers are placed under by the healthcare
system [16]. This is common in patients with multimor-
bidity as they manage an increasingly chaotic medical
lifestyle. They must negotiate their way through multiple
fragmented appointments, investigations and medication
regimes. As well as being disruptive for the patient this
can also affect adherence [17]. The solution is “minim-
ally disruptive medicine” which aims to reduce the work-
load of managing illness by better co-ordinating care
and emphasising patient choice [17].
Resources
Managing multimorbidity is hard work for patients [18, 19],
and for practitioners [9, 19], especially when compounded
with socioeconomic deprivation. Managing patients with
multimorbidity is also financially costly. The more long
term conditions a patient has then the greater their use,
and thus cost, of health care. This includes primary care,
secondary care outpatient visits, and hospital admissions
[20]. This is also true of potentially avoidable acute admis-
sions, which are increased by multimorbidity, deprivation
and mental health problems [21]. There is a growing
recognition that with increasing levels of multimorbidity
the sustainability of current healthcare systems around the
world is under threat [22].
Mental-physical multimorbidity
Mental health problems such as depression are known
to be common in patients with multimorbidity and the
prevalence of mental health problems increases in a lin-
ear way with increasing numbers of physical conditions
within individuals [3, 23]. This has several negative con-
sequences, including the ability of the patient to manage
their conditions. Mental-physical multimorbidity is 2–3
times more common in patients living in deprived
areas compare to those in affluent areas, and thus
presents the GP with increased complexity [1, 24].
Recent work suggests that a collaborative care model
may help patients with mental-physical multimorbid-
ity in primary care [25].
Primary care systems
It is commonplace for general practices in the UK to
offer 10 min appointments to patients regardless of the
complexity of their health problem. This is unlikely to
be long enough to comprehensively deal with the com-
plex issues which arise in multimorbidity. In addition, in
areas of high deprivation the inverse care law continues
to exist, leading to shorter consultations, less patient en-
ablement and higher GP stress [26, 27]. Giving longer
consultations to patients with complex needs in deprived
areas can increase patient enablement and reduce GP
stress [28].
Continuity of care is an important part of the manage-
ment of patients with complex health conditions [29].
Patients value seeing the same doctor [30], however this
has become more difficult with the primary care reforms
in the UK [31].
Conclusion
Patients with multimorbidity have complex healthcare
needs. There are many challenges faced in the manage-
ment of multimorbidity, requiring a holistic approach by
a generalist in order to balance the often competing pri-
orities of single-disease, target based management of
multiple long term conditions and the overall wellbeing
of the individual. Healthcare systems will need to radic-
ally change their approaches to meet the challenges and
complexity that multimorbidity presents.
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